bites for 5 days after fever onset to avoid infecting naive mosquitoes and help break the transmission cycle. 1 Those who recover likely have long-lasting immunity. 1 To prevent mosquito bites that may lead to YFV disease, people in endemic areas should wear long-sleeved shirts and pants while outside when feasible, apply insect repellant when going outdoors, and use window screens or air-conditioning to keep mosquitoes outside. 1 There is also a live YFV vaccine (17D) available for those living in or traveling to endemic areas (travelers can find vaccine recommendations at https://wwwnc.cdc.gov/travel/), with >99% of vaccinated persons developing protective neutralizing antibodies within 4 weeks across most studies. 2, 4 Rarely, serious adverse events have been associated with the vaccine (estimated at 4.7 events per 100 000 doses) including anaphylaxis, "viserotropic" multi-organ disease, and neurologic complications such as meningitis, encephalitis, myelitis, acute disseminated encephalomyelitis, cranial neuropathies, or Guillain-Barré syndrome. 2, 4, 5 Such YFV vaccine-associated neurologic disease (YFV-AND) occurs approximately at 0.8 events per 100 000 vaccine doses, with higher rates in those over age 60. 2, 4, 5 As opposed to natural YFV infection, CSF pleocytosis can often be seen with some types of YFV-AND, suggesting CNS viral invasion or neuroinflammation may play a role. 2 Treatment for any YFV-AND should be tailored to the specific clinical neurologic syndrome. 4 Neurologists should consider YFV disease in those with the appropriate clinical syndrome who live in or have recently traveled to YFV endemic areas and should be aware of potential adverse neurologic events associated with the YFV vaccine. Suspected cases should be reported to local public health authorities. The latest information on YFV (and its vaccine) can be found in the Centers for Disease Control and Prevention's Website. 1 
